@article{2952811,
    title = "iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia. Phase 3 trial of ibrutinib plus rituximab in Waldenström’s macroglobulinemia",
    author = "Dimopoulos, MA and Tedeschi, A and Trotman, J and Garca-Sanz, R and Macdonald, D and Leblond, V and Mahe, B and Herbaux, C and Tam, C and Orsucci, L and others",
    journal = "N Engl J Med",
    year = "2018",
    volume = "378",
    number = "25",
    pages = "2399--2410"
}